Professional Summary »
Specializing In »
Practice Locations »
Patient Ratings »
Referring Physicians »
Professional Summary
Education & Certifications
- Board Certification: American Board of Internal Medicine, Medical Oncology (2019)
- Board Certification, Hematology, American Board of Internal Medicine (2019)
- Board Certification, Oncology, American Board of Internal Medicine (2019)
- Board Certification, Internal Medicine, American Board of Internal Medicine (2015)
- Fellowship: Stanford University Hematology and Oncology Fellowship (2019) CA
- Residency, Stanford University, Internal Medicine Residency, CA (2015)
- Medical Education: Stanford University School of Medicine (2012) CA
Honors & Awards
- Charles Dorsey Armstrong Award for Excellence in Patient Care by a Senior Resident, Department of Internal Medicine, Stanford Hospital and Clinics (2015)
- Humanism in Hematology/Oncology Award, Division of Oncology, Stanford Hospital and Clinics (2019)
- Methods in Clinical Cancer Research Workshop, ASCO/AACR (2019)
Publications
-
G328E and G409E sialin missense mutations similarly impair transport activity, but differentially affect trafficking
Myall, N. J., Wreden, C. C., Wlizla, M., & Reimer, R. J. (2007). G328E and G409E sialin missense mutations similarly impair transport activity, but differentially affect trafficking. MOLECULAR GENETICS AND METABOLISM, 92(4), 371–74. -
Tract Profiles of White Matter Properties: Automating Fiber-Tract Quantification
Yeatman, J. D., Dougherty, R. F., Myall, N. J., Wandell, B. A., & Feldman, H. M. (2012). Tract Profiles of White Matter Properties: Automating Fiber-Tract Quantification. PLOS ONE, 7(11). -
Case series: fractional anisotropy along the trajectory of selected white matter tracts in adolescents born preterm with ventricular dilation.
Myall, N. J., Yeom, K. W., Yeatman, J. D., Gaman-Bean, S., & Feldman, H. M. (2013). Case series: fractional anisotropy along the trajectory of selected white matter tracts in adolescents born preterm with ventricular dilation. Journal of Child Neurology, 28(6), 771–77. -
Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.
Myall, N. J., Neal, J. W., Cho-Phan, C. D., Zhou, L. Y., Stehr, H., Zhou, L., … Wakelee, H. A. (2016). Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene. Clinical Lung Cancer, 17(2), e17–21. -
Variations in the neurobiology of reading in children and adolescents born full term and preterm
Travis, K. E., Ben-Shachar, M., Myall, N. J., & Feldman, H. M. (2016). Variations in the neurobiology of reading in children and adolescents born full term and preterm. NEUROIMAGE-CLINICAL, 11, 555–65. -
Adding to the targeted therapy toolbox: BRAF and MEK inhibition in the treatment of BRAF V600E metastatic non-small cell lung cancer
Myall, N. J., & Wakelee, H. A. (2016). Adding to the targeted therapy toolbox: BRAF and MEK inhibition in the treatment of BRAF V600E metastatic non-small cell lung cancer. TRANSLATIONAL CANCER RESEARCH, 5, S1233–S1240. -
-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.
Baik, C. S., Myall, N. J., & Wakelee, H. A. (2017). -Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy. Oncologist. -
Developmental Changes within White Matter Tracts of Healthy Children Age 9 to 16 Years Old
Yeatman, J. D., Myall, N. J., Dougherty, R. F., Wandell, B. A., & Feldman, H. M. (2013). Developmental Changes within White Matter Tracts of Healthy Children Age 9 to 16 Years Old. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 34(6), S5. -
Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non-small-cell Lung Cancer.
Myall, N. J., Henry, S., Wood, D., Neal, J. W., Han, S. S., Padda, S. K., & Wakelee, H. A. (2018). Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non-small-cell Lung Cancer. Clinical Lung Cancer. -
Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer
Horn, L., Bauml, J., Forde, P. M., Davis, K. L., Myall, N. J., Sasane, M., … Johnson, B. E. (2019). Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer. LUNG CANCER, 128, 74–90. -
Advances in the Treatment of Stage III Non-Small Cell Lung Cancer.
Myall, N. J., & Das, M. (2020). Advances in the Treatment of Stage III Non-Small Cell Lung Cancer. Clinics in Chest Medicine, 41(2), 211–22. -
Safety of lorlatinib following alectinib-induced pneumonitis in two patients with ALK-rearranged non-small cell lung cancer: a case series.
Myall, N. J., Lei, A. Q., & Wakelee, H. A. (2021). Safety of lorlatinib following alectinib-induced pneumonitis in two patients with ALK-rearranged non-small cell lung cancer: a case series. Translational Lung Cancer Research, 10(1), 487–95. -
Pharmacovigilance analysis of cardiac toxicities associated with targeted therapies for metastatic non-small cell lung carcinoma.
Waliany, S., Zhu, H., Wakelee, H., Padda, S. K., Das, M., Ramchandran, K., … Neal, J. W. (2021). Pharmacovigilance analysis of cardiac toxicities associated with targeted therapies for metastatic non-small cell lung carcinoma. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. -
Brain Metastases in EGFR- and ALK-positive Non-Small Cell Lung Cancer: Outcomes of CNS Penetrant Tyrosine Kinase Inhibitors (TKIs) Alone versus in Combination with Radiation.
Thomas, N. J., Myall, N. J., Sun, F., Patil, T., Mushtaq, R., Yu, C., … McCoach, C. E. (2021). Brain Metastases in EGFR- and ALK-positive Non-Small Cell Lung Cancer: Outcomes of CNS Penetrant Tyrosine Kinase Inhibitors (TKIs) Alone versus in Combination with Radiation. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. -
Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies.
Myall, N. J., Yu, H., Soltys, S. G., Wakelee, H. A., & Pollom, E. (2021). Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies. Neuro-Oncology Advances, 3(Suppl 5), v52–v62. -
In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?"
Thomas, N. J., Myall, N. J., Sun, F., Patil, T., Mushtaq, R., Yu, C., … McCoach, C. E. (1800). In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?". Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 17(2), e12–e14. -
Characterization of Metastatic Non-Small Cell Lung Cancer and Oligometastatic Incidence in an Era of Changing Treatment Paradigms.
No, H. J., Raja, N., Von Eyben, R., Das, M., Roy, M., Myall, N., … Vitzthum, L. K. (2022). Characterization of Metastatic Non-Small Cell Lung Cancer and Oligometastatic Incidence in an Era of Changing Treatment Paradigms. International Journal of Radiation Oncology, Biology, Physics. -
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report.
Gu, X., Wang, W., Wu, W., Zhang, Y., Shao, L., Santarpia, M., … Lou, G. (2022). Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report. Translational Lung Cancer Research, 11(5), 902–909. -
Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based Regimens.
Waliany, S., Wakelee, H., Ramchandran, K., Das, M., Huang, J., Myall, N., … Neal, J. W. (2022). Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based Regimens. Clinical Lung Cancer. -
Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on BRAF: Case Series and Literature Review of Treatment.
Giustini, N. P., Patel, S. P., Myall, N. J., Fernando do Prado Moura, J., Kulkarni, A., Chao, R. C., … Bazhenova, L. (2022). Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on BRAF: Case Series and Literature Review of Treatment. JCO Precision Oncology, 6, e2100551. -
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.
Dankner, M., Wang, Y., Fazelzad, R., Johnson, B., Nebhan, C. A., Dagogo-Jack, I., … Rose, A. A. (2022). Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors. JCO Precision Oncology, 6, e2200107. -
Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes.
Wu, J., Ding, V., Luo, S., Choi, E., Hellyer, J., Myall, N., … Han, S. S. (2022). Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes. JCO Precision Oncology, 6, e2200220. -
Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer.
Hui, C., Qu, V., Wang, J.-Y. Y., von Eyben, R., Chang, Y.-C. C., Chiang, P.-L. L., … Pollom, E. (2022). Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer. Journal of Neuro-Oncology. -
Implementation and efficacy of a fellow-led, case-based noon lecture series.
Dickerson, J., Myall, N. J., Roy, M., & Johnson, T. P. (2022). Implementation and efficacy of a fellow-led, case-based noon lecture series. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Use of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer.
Gensheimer, M. F., Gupta, D., Patel, M. I., Fardeen, T., Hildebrand, R., Teuteberg, W., … Ramchandran, K. (2022). Use of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer. JCO Oncology Practice, OP2200128. -
Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple Myeloma.
Myall, N. J., Wang, S. X., Hall, E. T., Witteles, W. H., Leung, L., Dunn, T. J., & Hong, W.-J. J. (2022). Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple Myeloma. Federal Practitioner : for the Health Care Professionals of the VA, DoD, and PHS, 39(Suppl 3), S56–S62. -
Pharmacovigilance Analysis of HeartFailure Associated With Anti-HER2 Monotherapies and Combination Regimens for Cancer.
Waliany, S., Caswell-Jin, J., Riaz, F., Myall, N., Zhu, H., Witteles, R. M., & Neal, J. W. (2023). Pharmacovigilance Analysis of HeartFailure Associated With Anti-HER2 Monotherapies and Combination Regimens for Cancer. JACC. CardioOncology, 5(1), 85–98. -
Local Control of Brain Metastases with Osimertinib Alone in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
Hui, C., Qu, V., Wang, J. Y., Von Eyben, R., Chang, Y. C., Chiang, P. L., … Pollom, E. (2022). Local Control of Brain Metastases with Osimertinib Alone in Patients with EGFR-Mutant Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC. -
Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung Cancer.
Su, C. C., Wu, J. T., Choi, E., Myall, N. J., Neal, J. W., Kurian, A. W., … Han, S. S. (2023). Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung Cancer. JAMA Network Open, 6(9), e2335813. -
BRIEF REPORT: Real-world efficacy and safety of amivantamab for EGFR-mutant non-small cell lung cancer (NSCLC).
Wang, K., Du, R., Myall, N. J., Lewis, W. E., Uy, N., Hong, L., … Le, X. (2023). BRIEF REPORT: Real-world efficacy and safety of amivantamab for EGFR-mutant non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. -
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial.
Hui, C., Brown, E., Wong, S., Das, M., Wakelee, H., Neal, J., … Vitzthum, L. K. (2023). Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial. Clinical Lung Cancer. -
Advancements without consensus: differing practice patterns highlight unanswered questions in the management of brain metastases from<i> EGFR-</i> and<i> ALK</i>-positive non-small cell lung cancer
Hui, C., Pollom, E. L., Li, G., & Myall, N. J. (2023). Advancements without consensus: differing practice patterns highlight unanswered questions in the management of brain metastases from EGFR- and ALK-positive non-small cell lung cancer. JOURNAL OF THORACIC DISEASE.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Thoracic Cancer Program in Palo Alto Palo Alto, CA
Palo Alto, CA
Thoracic Cancer Program in Palo Alto
875 Blake Wilbur Drive
Palo Alto , CA 94304
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(87 reviews)
Dr. Myall is a fantastic communicator. He explains everything and listens to all my questions and concerns. He lets me know he is available if I need him when health issues arise.
Dr. Myall is the best Dr. I travel from Turlock every two weeks to see him. I trust him completely with my Healthcare. I'm so glad it was Dr. Myall I got my first appointment with back in April 2023.
Great patient doctor.
Excellent doctor! I could not do better.
Dr Myall is an excellent communicator.
Wonderful doctor.
He is great, knowledgeable, caring, and overall wonderful doctor, not only in his specified field, but overall.
I am very happy with the care I received from Dr. Myall.
Dr. Mayall is very thorough in his questioning. Talking to anyone about health issues is not easy but Mayall is very empathetic...
Very thorough Doctor and very concerned about all phases of my treatment
Dr Myall is a very effective oncologist. He listens, responds in detail, and makes sure I know that he is available for any questions I may have in the future.
He is an excellent physician and communicator.
EXcellent doctor.
Very supportive, compassionate, and caring.
Dr. Myall is very well-versed in his field of expertise. With me he is dealing with a rare type of cancer. He is always willing to consider that what I am experiencing may not be related to my cancer, but also could be some thing that is related to the cancer, but not yet known by the doctors. He is always willing to look into it.
Dr. Myall is an excellent analyst of chest CT scan images who shows unique and profound understanding of such images that I have not observed in anyone else. He doesn't just say everything turned out well--nothing to worry about. Rather, he gives a clear comparison to changes in nodules from the previous CT scans and the meaning and reasons those changes mean things turned out well. At the same time, he reassures that he and his staff will be watching the nature of those changes carefully in future CT's. He helped me understand the meaning of my CT scan. He is an optimistic and caring physician and a very relatable person. When I expressed that I was going through a lot of stress on three different issues, he empathized with me and made the comment that we only have "so much emotional bandwidth to handle that stress. He offered to have social services give me a call to help determine if such services would help me. I appreciate his "whole person" approach and kind compassion. Of course, you know that Dr. Myall has some sort of speech impediment. That speech impediment is not an issue in our communication. I have learned to focus in on what he has to say, and if I am not sure I heard right, I paraphrase it for him to confirm or clarify. It works.
Great doctor. He and the team treating me has given me 3 years and expect there will be more. What a gentleman.
I am very happy that Dr. Myall is my doctor and he is consern about
my health. Trust him 100%
I tell everyone I know about Stanford - best health care ever! Beautifully clean facility. Science-based medicine, and everyone is friendly and helpful! BTW, best front desk people I have ever run into.
He is considerate, informative and friendly.
He is very proficient at his job and cares about his work and patients
Dr. Myall is a very caring and professional doctor. When I have any issues, he and his team are extremely fast at responding to my needs. I know they have many patients, but they make me feel like my needs are very important to them.
Excellent communicator, very kind, and very supportive.
Very knowledgeable about my condition. Good information and listened to my concerns.
Dr. Myall was very informative. He explained things very clearly. Dr. Myall answer d all of our questions.
Dr. Myall is a very knowledgeable, compassionate doctor.
Dr. Myall is very responsible!
Dr Myall is very thorough, friendly, caring, knowledgeable. He always makes me feel comfortable, asks lots of questions, which is great because it reminds me of things I’ve forgotten to bring up. He makes the appointment all about me, and lets me help make my health decisions after fully informing me on all options. HE LISTENS AND RESPONDS! Can’t find that too much anymore!
Could not understand anything he/she was saying
I appreciate Dr. Myall's support, encouragement and understanding of my case and current condition. His interpretation of my CT Scan results helps me understand better what is occurring inside my lungs. The fact that he used vocabulary that was more specific than the written report from my local CT radiologist gave me clues in how to proceed in my healing process. In place of the phrase, "irregular airspace disease" Dr. Myall spoke the words "irregular inflammation" in the lung that received surgery one year ago. We discussed how the increased exercise (walking, treadmilling, yoga, tai chi that I am engaging in, along with a variety of breathing exercises are helpful in resolving the airspace inflammation.
I am also thankful to him for noticing on a previous visit that I felt alone and out of contact with people and following up by putting me in contact with Stanford's Lung Cancer Support run by Lynn Chao once a month. He also, previously helped me make contact with an integrated medicine doctor at UCSF with whom I have an upcoming appointment in June. So, overall, Dr. Myall is naturally insightful and supportive.
I believe and trust Dr.Myall. He seems very knowledgeable and gives me confidence he can help me with my severe cancer. What ever happens I think Dr,Myall gave it 100% and I thank him for that.
he is an extremely caring doctor
He is a very caring, knowledgeable and is very professional.
I feel Dr. Myall and his team is very interested in keeping my care the best it can be, and keeping me comfortable. They respond quickly to my needs and concerns.
Dr Myall covered all bases. He did a thorough job of connecting with my current healthcare and problems outside of his specialty. I had little problems understanding him at times, but that is partly due to my minor hearing loss. Dr Myall is a caring, informed doctor.
Dr. Myall is a thoughtful and thorough physician. He is very helpful with making me feel at ease regarding my involvement in the study. I feel completely informed about the processes and, more importantly, I feel completely listened to.
Thanks Dr. Myall!
I am very pleased with the care and concern shown by Dr. Myall.
From Tiffany to Doctor Myall I’m very satisfied.
He is an exceptional physician. He is very caring and compassionate. He always asks about any issues I may be having and develops a plan to correct them.
He is a very caring person a knowledgeable Dr.
Nathan Myall was kind and concerned and asked about me. I am doing ok so I really had no problems or questions for him. It was just a very frustrating visit for me because of the video connection.
He was very thorough, answered all our questions, and made me comfortable with my decision regarding the clinical trial.
He is a very knowledgeable, caring doctor. You are very lucky to have him on your staff.
I really liked Dr. Myall. He is professional, knowledgable, and clearly cares about his patients, i.e., me. I also liked his nurse Jason Kao.
Dr. Myall has some trouble speaking clearly, but for the most part, I understood him. He explains things clearly, informed me well, gave me his recommendation (when I asked for it), and fully supported my ultimate decision re: my treatment.
Dr. Myall has given me excellent service.
Very good doctor
Excellent physician. Would recommend him to others.
Dr. Myall makes it clear to me that my quality of life is important to him. He always follows up with me if he thinks of a better treatment or medicine that he thinks would work better than what I am currently using. I am very confident with his knowledge and compassion that he demonstrates.
Dr. Myall is a very thorough and caring physician. He has done everything possible and spent much time on my case. I feel fortunate that he is my Oncologist. for my case
He continues to be a very knowledgeable and compassionate care provider. He puts my heath and comfort first.
was able to answer my questions
Very good
Dr. Myall is an excellent physician, takes time to answer all of the patient's questions, and is very concerned about the patient's welfare and doing everything he can to help improve the patient's condition.
Dr. Myall was very thorough and was very patient with my questions. He explained everything very clearly. I'm very pleased with Dr. Myall.
Dr was very cordial and very thorough. I asked him everything I needed to know as of right now. I was not left wondering about anything. Thank You Dr Myall and Jay.
i appreciated dr Myall and his team to care and concern during my differcult time dealing my health issue. Dr Myall and his team make me feel comfortable to talk to regarding any issue should arise. Once again i would like to thanks and appreciated DR Myall and his team has done
Dr. Myall is a very knowledgeable and caring physician. I am very happy to have him oversee my care.
Very knowledgeable & patient
Dr. Myall is very caring, concise & careful to answer all my questions.
Excellent communication skills and very thorough. Dr. Myall was gracious and did not rush through the appointment. He answered all our questions. Wonderful doctor.
Dr. Myall is very knowledgeable and friendly. He’s answers all our questions clearly and provides additional info.
Dr. Myall is a very good doctor.
He is an excellent physician and is very concerned about his patients. He also very patiently answers all questions
excellent communicator-took the time to answer questions
I will eagerly recommend Dr Myall. He is a compassionate and very knowledgeable specialist.
Thank you to Dr Myall for being knowledgeable and understanding.
He collected all of the information about my health history and individualized his recommendations for me. I appreciate that I
can call back with questions that may arise.
He is fantastic.,,.. compassionate, and caring…..
I love everything about he and his team!!!
Very caring, knowledgeable and professional.
He's wonderful, compassionate, extremely knowledgeable, extremely efficient in that he's always prepared and informed I'm so thankful to have access to him. Thank him for me!
I very much like how much he pays attention to details. And he does listen to my concerns.
I'm very happy with my team doctors from day one . They find the best way to treat my cancer and closely monitor my issue. I'm highly recommend Stanford facility for their cancer treatments
My wife is now considering going back to Almaden Family Physicians since they are now part of the Stanford network.
He's wonderful. Thorough, knowledgeable, patient. So thankful to be able to work with him!! Thank you!!
He is very thorough and patient. He addresses all my concerns and has helped me in so many ways.
Very easy to understand and comprehend all that he said
Excellent
Dr. Myall is a good listener, informative and personable. Dr. Myall's pleasant personality comes across very well via video conference such that I felt I was meeting with him in person. The reason I consulted Dr. Myall's office was for a second opinion, and a backup opinion, regarding my proposed new course of treatment . . . and he provided both, totally meeting my expectations. My husband and I reside in Oregon and we were grateful Dr. Myall was willing to provide a second opinion via video conference. Because of my concerns about COVID and the Delta variant, I wanted to avoid flying, even to the beautiful state of California. I'm vaccinated, of course -- but it seems many vaccinated people are contracting Covid and flying appears to be an easy means of transmission.
Dr. Myall was very specific and thorough in answering my questions. I had many questions and I took up a lot of his time, but he was very patient and helpful in addressing all of my concerns. I feel confident in the information Dr. Myall provided me during my visit.
I am currently dealing with a serious health condition. Dr. Myall was direct in explaining the nature of my illness and the medical options available to me. His approach was reassuring and positive. I am grateful for that.
Very thorough.. very empathetic.
Only wish audio was better.
Wonderful doctors. Explained everything so well and he took his time
He is very kind and knowledgeable.
He's hard to understand and can be repetitive.
I liked him immediately. Caring and smart. I have confidence he will help me
Dr. Myall is extremely thorough in his recommendations. for treatment. He is very caring and considers my feelings regarding my treatment.
Excellent
For me, he seems nice enough but, I had a difficult time understanding him. I am looking forward to his written report of his assessment of my case.
Dr. Myall seems to be a kind, knowledgeable physician. I look forward to his guidance through my health journey!
See earlier comments.
View More »
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records